Yingkuang Liang (Yingkuan Liang)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Top Venues

Clinical and translational medicine

Cell death and differentiation

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Haitao Huang, Na Li, Yingkuang Liang, Rutao Li, Xing Tong, Jinyuan Xiao, Hongzhen Tang, Dong Jiang, Kai Xie, Chen Fang, Shaomu Chen, Guangbin Li, Bin Wang, Jiaqian Wang, Haitao Luo, Lingchuan Guo, Haitao Ma, Wei Jiang, Yu Feng
Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma. Clinical and translational medicine 13 (11) (2023)
Yipeng Feng, Te Zhang, Zeyu Zhang, Yingkuang Liang, Hui Wang, Yuzhong Chen, Xinnian Yu, Xuming Song, Qixing Mao, Wenjie Xia, Bing Chen, Lin Xu, Gaochao Dong, Feng Jiang
The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma. Cell death & disease 14 (8) (2023)
Hui Wang, Yingkuang Liang, Te Zhang, Xinnian Yu, Xuming Song, Yuzhong Chen, Qixing Mao, Wenjie Xia, Bing Chen, Lin Xu, Gaochao Dong, Feng Jiang
C-IGF1R encoded by cIGF1R acts as a molecular switch to restrict mitophagy of drug-tolerant persister tumour cells in non-small cell lung cancer. Cell death and differentiation (2023)
Yingkuang Liang, Qixing Mao, Lin Wang, Wenjie Xia, Bing Chen, Hui Wang, Rutao Li, Lin Xu, Feng Jiang, Gaochao Dong
CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification. Clinical and translational medicine 11 (9) (2022)